Zobrazeno 1 - 10
of 639
pro vyhledávání: '"Trial participation"'
Autor:
Hyunmin Yu, José Bauermeister, Ufuoma Oyiborhoro, Knashawn Morales, Subhash Aryal, Karen Glanz, Antonia Villarruel, Stephen Bonett
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The Coronavirus Disease 2019 (COVID-19) pandemic precipitated an urgent need for clinical trials to discover safe and efficacious treatments. We examined how COVID-19 experiences, clinical trial awareness, and trust in the vaccine
Externí odkaz:
https://doaj.org/article/ef63207c0c7a461898a106dd061135b7
Autor:
Melanie H. Jacobson, Emily Yost, Shirley V. Sylvester, Cheryl Renz, Diego F. Wyszynski, Kourtney J. Davis
Publikováno v:
BMC Pregnancy and Childbirth, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Due to the exclusion of pregnant and lactating people from most clinical trials, there is an incomplete understanding of the risks and benefits of medication use in these populations and therapeutic decision-making is often conduc
Externí odkaz:
https://doaj.org/article/20e54982a94f425ebe026aac7fd4d92c
Autor:
Anne Rivelli, Osondi Ozoani-Lohrer, Cheryl Lefaiver, Maureen Shields, Andy Marek, Mercedes Robaina, Veronica Fitzpatrick
Publikováno v:
Contemporary Clinical Trials Communications, Vol 41, Iss , Pp 101353- (2024)
Background: To explore the association between ethnicity, as a proxy for language, and participation in clinical trials (CT) conducted by Principal Investigators (PI) who speak one or more language in addition to English. Methods: This retrospective,
Externí odkaz:
https://doaj.org/article/61c4df67a00a439888c9e5f640249ff1
Autor:
Maggie Tabberer, Nicola Williamson, Sophi Tatlock, Adam Gater, Rebecca Grimes, Chika Akinseye, David Neil, Aoife Mahon-Smith, Linda Nelsen
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-14 (2024)
Abstract Background Chronic obstructive pulmonary disease (COPD) and muscle weakness can cause impaired physical function, significantly impacting patients’ health-related quality of life (HRQoL). Loss of muscle strength is usually assessed through
Externí odkaz:
https://doaj.org/article/c9b41cbf936b4a06a8b85fdcffd752d7
Autor:
Catrin Henriksson, Anneli Olsson, Kasper Andersen, Gabriel Arefalk, David Erlinge, Robin Hofmann, Wilhelm Ridderstråle, Annika Rutgersson, Jonas Oldgren, Stefan James
Publikováno v:
Contemporary Clinical Trials Communications, Vol 40, Iss , Pp 101307- (2024)
Background: The participation of patients in clinical trials is crucial for the development of healthcare. There are several challenges in the recruitment of trial participants with acute medical conditions. The registry-based randomized DAPA-MI clin
Externí odkaz:
https://doaj.org/article/7014313ae53a48eaa10e2dae61abed31
Autor:
Anne Rivelli, Cheryl Lefaiver, Maureen Shields, Osondi Ozoani-Lohrer, Andy Marek, Jana Hirschtick, Veronica Fitzpatrick
Publikováno v:
Contemporary Clinical Trials Communications, Vol 38, Iss , Pp 101274- (2024)
Background: Representativeness in clinical trials (CT) serves as a metric of access to healthcare and reflects differences that may determine differential efficacy of medical interventions; thus, quantifying representativeness in CT participation is
Externí odkaz:
https://doaj.org/article/dfe941f3ebb140039eb6d154485a1100
Autor:
Mary Murphy, Eilís McCaughan, Gareth Thompson, Matthew A Carson, Jeffrey R Hanna, Monica Donovan, Richard H Wilson, Donna Fitzsimons
Publikováno v:
BMC Palliative Care, Vol 22, Iss 1, Pp 1-8 (2023)
Abstract Background Clinical trial participation for patients with non-curative cancer is unlikely to present personal clinical benefit, which raises the bar for informed consent. Previous work demonstrates that decisions by patients in this setting
Externí odkaz:
https://doaj.org/article/5047560cdc3943bb8f79d08024e49579
Autor:
Anne Wilhøft Kristensen, Annesofie Lunde Jensen, Kenneth Jensen, Susanne Oksbjerre Dalton, Jeppe Friborg, Cai Grau
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 29, Iss , Pp 100230- (2024)
Introduction: Clinical trials lead the progress in healthcare. To ensure reliable research conclusions, it is essential to enroll diverse patient groups. Identifying and understanding patient-reported barriers to clinical trials may help enhance recr
Externí odkaz:
https://doaj.org/article/7fe35dc691b34bd49f8accdb126ca731
Autor:
Christine M. Weston, Elizabeth L. Andrade, Wuraola Olawole, Monica Guerrero Vazquez, Hailey Miller, Sarah C. Stevens, Cyd Lacanienta, Nancy Perrin, Mark C. Edberg, Thomas A. Mellman, Yvonne Bronner, Roger Clark, Cheryl R. Dennison Himmelfarb
Publikováno v:
Journal of Clinical and Translational Science, Vol 8 (2024)
Abstract Introduction: Black and Latino individuals are underrepresented in COVID-19 treatment and vaccine clinical trials, calling for an examination of factors that may predict willingness to participate in trials. Methods: We administered the C
Externí odkaz:
https://doaj.org/article/2e6abea3f33c4eec8a5b9ce40ed02833
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-20 (2022)
Abstract Objectives Existing research on the perspectives of patients with cancer and health care professionals indicates that patient decision making on cancer clinical trial participation is a complex process and may be poorly understood, possibly
Externí odkaz:
https://doaj.org/article/29b8cf47256d493085bc12b92beaacea